Dexycu is a Intraocular Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eyepoint Pharmaceuticals Us, Inc. The primary component is Dexamethasone.
Product ID | 71879-001_60524f04-13ae-4b19-8da0-41d141f7b574 |
NDC | 71879-001 |
Product Type | Human Prescription Drug |
Proprietary Name | Dexycu |
Generic Name | Dexamethasone |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAOCULAR |
Marketing Start Date | 2018-05-22 |
Marketing Category | NDA / NDA |
Application Number | NDA208912 |
Labeler Name | EyePoint Pharmaceuticals US, Inc |
Substance Name | DEXAMETHASONE |
Active Ingredient Strength | 517 ug/.005mL |
Pharm Classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2018-05-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208912 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-03-11 |
Ingredient | Strength |
---|---|
DEXAMETHASONE | 517 ug/.005mL |
SPL SET ID: | 583d70ed-bc42-465b-983d-c770db58406f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
71879-001 | Dexycu | Dexycu |
0054-3177 | Dexamethasone | Dexamethasone |
0054-4179 | Dexamethasone | Dexamethasone |
0054-4180 | Dexamethasone | Dexamethasone |
0054-4181 | Dexamethasone | Dexamethasone |
0054-4182 | Dexamethasone | Dexamethasone |
0054-4183 | Dexamethasone | Dexamethasone |
0054-4184 | Dexamethasone | Dexamethasone |
0054-4186 | Dexamethasone | Dexamethasone |
0054-8174 | Dexamethasone | Dexamethasone |
0023-3348 | OZURDEX | dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DEXYCU 86725761 5734181 Live/Registered |
Icon Bioscience, Inc. 2015-08-14 |